Home » Health » Anima Research Center in Alken Leading World’s First Study on Improved Antibody Treatment for Omikron Variant of COVID-19

Anima Research Center in Alken Leading World’s First Study on Improved Antibody Treatment for Omikron Variant of COVID-19

by David Bijnens

Anima Research Center in Alken will soon participate in a new study into improved antibody treatment against the corona virus. This extra shot, on top of the vaccine, should sufficiently protect the most vulnerable patients against the omikron variant of the covid virus: a world first. Anima Research Center will test the new antibody treatment on behalf of pharmaceutical company AstraZeneca. The research should yield the first results by the autumn. Then our country will start with the fifth vaccination campaign against the corona virus.

2023-06-28 16:30:00
#World #Alken #research #center #tests #improved #antibody #treatment #omikron #variant

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.